Brazil Pharma Plans to Raise Up to $328 Million in Initial Public Offering

Brazil Pharma SA, the pharmacy unit of Banco BTG Pactual SA, is seeking to raise as much as 519.8 million reais ($328 million) in an initial public offering.

Brazil Pharma plans to sell as many as 27 million shares, including possible supplementary offerings, according to a prospectus published today in Sao Paulo-based newspaper Valor Economico. The stock may be priced at 16.25 reais to 19.25 reais, Brazil Pharma said.

BTG Pactual is coordinating the offering with Morgan Stanley and Banco Bradesco BBI SA. The stock is likely to be priced on June 22 and will start trading June 27.

To contact the reporter on this story: Laura Price in London at lprice3@bloomberg.net

To contact the editor responsible for this story: Chris Peterson at cpeterson@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.